Literature DB >> 15491428

The future incidence of cutaneous melanoma within the UK.

B L Diffey1.   

Abstract

BACKGROUND: The incidence of cutaneous malignant melanoma continues to rise in the U.K., where since the 1970s malignant melanoma has seen the largest increase in incidence rates compared with other major cancers. To counteract this rise, sun awareness campaigns have been introduced in this and several other countries since the 1980s with the object of encouraging people to limit their exposure to strong sunshine and to avoid sunburn in the expectation that these interventions will act favourably on skin cancer incidence.
OBJECTIVES: To predict the incidence of cutaneous malignant melanoma in the British population over the next half-century as a consequence of either a stabilization or a reduction in lifetime risk of melanoma for recent and future birth cohorts so that cancer services can be planned appropriately over the coming years.
METHODS: An age-cohort model has been developed that estimates future incidence rates of melanoma in the U.K.
RESULTS: The results suggest that the benefits of intervention strategies, assuming that these will translate eventually into a downturn in melanoma incidence, may not be seen for another 30 years or so, by which time the predicted age-standardized rate of melanoma may be around twice that presently observed.
CONCLUSIONS: Prevention of deaths from melanoma depends on both reducing incidence and achieving earlier diagnosis. This analysis has indicated that the former is unlikely to be realized in the U.K. for some decades, and so early detection of suspected lesions, with prompt surgery to remove confirmed tumours, is paramount if mortality from melanoma is to be kept in check.

Entities:  

Mesh:

Year:  2004        PMID: 15491428     DOI: 10.1111/j.1365-2133.2004.06216.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  7 in total

1.  Do white British children and adolescents get enough sunlight?

Authors:  Brian Diffey
Journal:  BMJ       Date:  2005-07-02

Review 2.  Melanomas in renal transplant recipients: the London experience, and invitation to participate in a European study.

Authors:  V L Brown; R N Matin; R Cerio; M E Leedham-Green; C M Proby; C A Harwood
Journal:  Br J Dermatol       Date:  2007-01       Impact factor: 9.302

3.  Accuracy of SIAscopy for pigmented skin lesions encountered in primary care: development and validation of a new diagnostic algorithm.

Authors:  Jon D Emery; Judith Hunter; Per N Hall; Anthony J Watson; Marc Moncrieff; Fiona M Walter
Journal:  BMC Dermatol       Date:  2010-09-25

Review 4.  Epidemiology of invasive cutaneous melanoma.

Authors:  R M MacKie; A Hauschild; A M M Eggermont
Journal:  Ann Oncol       Date:  2009-08       Impact factor: 32.976

5.  Recognition of skin malignancy by general practitioners: observational study using data from a population-based randomised controlled trial.

Authors:  P Pockney; J Primrose; S George; N Jayatilleke; B Leppard; H Smith; P Little; R Kneebone; A Lowy
Journal:  Br J Cancer       Date:  2009-01-13       Impact factor: 7.640

Review 6.  Ultraviolet radiation, aging and the skin: prevention of damage by topical cAMP manipulation.

Authors:  Alexandra Amaro-Ortiz; Betty Yan; John A D'Orazio
Journal:  Molecules       Date:  2014-05-15       Impact factor: 4.411

7.  Melanoma incidence and mortality in Scotland 1979-2003.

Authors:  R M MacKie; C Bray; J Vestey; V Doherty; A Evans; D Thomson; M Nicolson
Journal:  Br J Cancer       Date:  2007-05-29       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.